Real-life impact on antimicrobial prescription of Syndromic Molecular Testing in adults hospitalized in infectious disease departments. Respiratory Syndromic Molecular Testing panel: Is it worth it? - 18/07/24
Highlights |
• | Distinguishing viral from bacterial infection during pneumonia is a major challenge. |
• | The impact of a respiratory Syndromic Molecular Testing panel is unknown. |
• | Identifying specific populations which could benefit from these expensive tests is crucial. |
Abstract |
Background |
While sensitive molecular diagnostic tests enable accurate and rapid diagnosis of many respiratory viruses, their impact on antibiotic management remains uncertain.
Our study aimed to evaluate the impact of respiratory syndromic molecular testing panel in real-life clinical practice.
Method |
Retrospective descriptive study involving consecutive hospitalized patients in an infectious disease department who had been prescribed a respiratory syndromic molecular testing panel on nasopharyngeal swab samples (FilmArray Respiratory Panel 2 plus) during hospitalization from October 1st, 2021, to February 28th, 2023.
Results |
All in all, 94 out of 210 screened patients were included in the study. Syndromic molecular testing results influenced antibiotic treatment in seven cases: discontinuation in four cases (three virus identifications), changes in two (Mycoplasma pneumoniae positive cases), and initiation in two (negative viral PCRs and one positive bacterial culture).
Conclusion |
In our study, respiratory syndromic molecular testing had low impact on antibiotic modification.
Le texte complet de cet article est disponible en PDF.Keywords : Respiratory tract infection, Community acquired pneumonia, Antibiotics, Virus, PCR
Plan
Vol 54 - N° 5
Article 104933- août 2024 Retour au numéro
Article précédent
- Hypervirulent Klebsiella pneumoniae-related bacteremia in intensive care unit: A retrospective cohort study
- Marin Moutel, Edwidge Peju, Martin Belan, Ariane Gavaud, Jean-Paul Mira, Caroline Charlier, Etienne Canouï, Nabil Gastli
- Investigation of a cluster of acute epiglottitis in Vendée, western France, October – December 2022
- Gwénola Picard, Pascaline Loury, Ronan Ollivier, Thomas Guimard, Jean-Claude Lacherade, Yves-Marie Vandamme, Farah Boukraa, Lisa A. King
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?